Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Apr'24
Apr'23
Apr'22
Apr'21
Apr'20
Apr'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
24.69
42.62
58.91
46.27
10.86
13.43
Shareholder's Funds
24.69
42.62
58.91
46.27
10.86
13.43
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
1.14
0.82
1.80
2.05
2.43
2.12
Secured Loans
1.14
0.82
1.80
2.05
2.43
2.12
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
4.24
5.65
6.34
1.21
1.15
1.53
Other Long Term Liabilities
13.06
10.39
11.27
1.98
2.7
3.11
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
13.06
10.39
7.10
3.22
3.06
2.37
Current Liabilities
Trade Payables
2.96
1.83
3.42
1.48
0.97
1.19
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
5.91
4.36
7.27
4.94
5.71
5.36
Total Liabilities
43.66
57.37
73.27
54.43
19.63
21.16
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
15.66
12.59
7.49
6.88
4.40
3.06
Less: Accumulated Depreciation
3.16
4.68
4.42
3.56
2.12
1.84
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
12.50
7.91
3.07
3.31
2.28
1.22
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.06
0.15
0.18
0.15
0.15
0.12
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Assets
35.30
44.99
43.96
14.71
14.09
14.80
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
1.56
1.52
1.26
0.98
0.59
0.59
Sundry Debtors
2.96
2.86
2.45
2.95
2.64
1.45
Cash and Bank
2.52
6.10
23.45
33.94
1.88
4.07
Other Current Assets
7.34
10.88
27.38
38.27
5.16
6.11
Short Term Loans and Advances
0.30
0.40
0.22
0.40
0.06
0.00
Total Current Assets
8.36
12.38
29.32
39.72
5.54
6.36
Net Current Assets (Including Current Investments)
2.45
8.02
22.05
34.78
-0.17
1.01
Total Current Assets Excluding Current Investments
8.36
12.38
29.32
39.72
5.54
6.36
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
43.66
57.37
73.27
54.43
19.63
21.16
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
1.14
0.82
1.80
2.05
2.43
2.12
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
YoY Growth in year ended Apr 2024 is 25.70% vs -7.81% in Apr 2023
Fixed Assets
YoY Growth in year ended Apr 2024 is 58.03% vs 157.65% in Apr 2023
Investments
YoY Growth in year ended Apr 2024 is -60.00% vs -16.67% in Apr 2023
Current Assets
YoY Growth in year ended Apr 2024 is -32.47% vs -57.78% in Apr 2023
Compare Balance Sheet Results of ImmunoPrecise Antibodies Ltd.
Figures in Million
Consolidated - Balance Sheet Results
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
24.69
51.21
-26.52
-51.79%
Shareholder's Funds
24.69
51.21
-26.52
-51.79%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
1.14
0.55
0.59
107.27%
Secured Loans
1.14
0.55
0.59
107.27%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
4.24
0
4.24
0.00%
Other Long Term Liabilities
13.06
6.68
6.38
95.51%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
13.06
6.68
6.38
95.51%
Current Liabilities
Trade Payables
2.96
8.69
-5.73
-65.94%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
5.91
24.65
-18.74
-76.02%
Total Liabilities
43.66
82.55
-38.89
-47.11%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
15.66
6.95
8.71
125.32%
Less: Accumulated Depreciation
3.16
5.89
-2.73
-46.35%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
12.50
1.06
11.44
1,079.25%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
0.06
0.10
-0.04
-40.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
0
0.71
-0.71
-100.00%
Total Non-Current Assets
35.30
1.88
33.42
1,777.66%
Current Assets Loans & Advances
Current Investments
0
0
0.00
0.00%
Inventories
1.56
0
1.56
0.00%
Sundry Debtors
2.96
0.29
2.67
920.69%
Cash and Bank
2.52
39.78
-37.26
-93.67%
Other Current Assets
7.34
63.45
-56.11
-88.43%
Short Term Loans and Advances
0.30
23.38
-23.08
-98.72%
Total Current Assets
8.36
80.67
-72.31
-89.64%
Net Current Assets (Including Current Investments)
2.45
56.01
-53.56
-95.63%
Total Current Assets Excluding Current Investments
8.36
80.67
-72.31
-89.64%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
43.66
82.55
-38.89
-47.11%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
1.14
0.55
0.59
107.27%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 0.00 Million
in Apr 2024Figures in Million
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 13.06 Million
in Apr 2024Figures in Million
YoY Growth in year ended Apr 2024 is 25.70% vs -7.81% in Apr 2023
Annual - Fixed Assets
Fixed Assets 12.50 Million
in Apr 2024Figures in Million
YoY Growth in year ended Apr 2024 is 58.03% vs 157.65% in Apr 2023
Annual - Investments
Investments 0.06 Million
in Apr 2024Figures in Million
YoY Growth in year ended Apr 2024 is -60.00% vs -16.67% in Apr 2023
Annual - Current Assets
Current Assets 8.36 Million
in Apr 2024Figures in Million
YoY Growth in year ended Apr 2024 is -32.47% vs -57.78% in Apr 2023






